Daily Newsletter

15 August 2023

Daily Newsletter

15 August 2023

LifeArc invests nearly $10m in Crick Institute’s Africa Scheme

The funding will extend support to the Institute’s Crick Africa Network for five years, supporting African scientists in infectious disease research.

Adam Zamecnik August 14 2023

British not-for-profit medical research organisation LifeArc has granted £7.5m ($9.5m) to the Francis Crick Institute’s Crick Africa Network to support African scientists.

The latest funding will extend the scheme by another five years, per the 14 August announcement.

The Crick Africa Network fellows will receive four years’ worth of funding that will be used at one of five African Institutions, including the University of Ghana’s West African Centre For Cell Biology of Infectious Pathogens, the South African University of Cape Town, and the London School of Hygiene & Tropical Medicines’ Medical Research Council Unit in The Gambia.

The fellows will be able to use the Crick’s platforms and collaboratively research with LifeArc’s facilities in Edinburgh and Stevenage. They will also receive mentorship and support in grant writing, publications, and research ethics, based on the announcement. LifeArc’s Academic Engagement team will also help the fellows in commercialisation and translational science.

In 2017, the Crick Africa Network was launched to research infectious diseases with the support of a £6m grant from the UK Government’s Global Challenges Research Fund. In the first cohort, the network has awarded over £11.6m to fellows in grant funding. Additionally, 97 students were supervised as part of the scheme, resulting in the release of 82 publications and the establishment of eight independent research groups.

Notably, biotech spin-out Yemaachi Biotechnology was launched since the Crick Africa Network’s establishment. The Ghanaian company seeks to optimise available molecular diagnostic and prognostic cancer tests for African populations.

The biotech also aims to identify new biomarkers for the early detection of cancer in African populations and develop new tools for their diagnosis, based on its website.

The Crick Africa Network will also now help African scientists with the management and development of science and technology platforms, which provide critical technical research support, as part of the one-year Technology Development Fellowship.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close